Newgen Software Technologies just reported Q1 2027 figures with revenue of ₹3,566.837 millions and net income of ₹628.211 millions, alongside a higher net margin compared with Q1 2026. For Newgen Software Technologies shareholders, the loss over the past year was 46.3%, including dividends. If you had bought the stock a year ago on the back of strong AI and cloud adoption stories, would this mix of better profitability and heavy share price damage change how you judged those earlier assumptions?
If the move has made Newgen Software Technologies harder to judge, start where the gap is still open and scan 195 high quality undervalued stocks .
The Two Stories Investors Were Arguing About On Newgen Software Technologies
The shares cost ₹893 at the start of the period, and Newgen Software Technologies sat between two very different stories that both sounded plausible.
On the optimistic side, the bullish view pointed to a Fair Value of ₹1,091. This price was implied by assumptions that AI led workflow tools, 17.6% annual revenue growth, and a future P/E of 46.4x could support stronger recurring subscription income.
The cautious camp leaned on a Fair Value of ₹835. This was based on concerns that low code rivals, 14.4% annual revenue growth, and compressed margins at 20.0% would come with tougher competition from global platforms.
What The Results Changed For Newgen Software Technologies
The clearest new fact for Newgen Software Technologies is the Q1 2027 print. Revenue was ₹3,566.837 millions and net income was ₹628.211 millions, compared with ₹3,206.563 millions and ₹497.206 millions in Q1 2026. Net margin moved from 15.5% to 17.6%. That shift in profitability supported more of the optimistic case than the cautious one, although only over a single quarter.
The useful takeaway is about testable assumptions. When a thesis leans on stronger recurring income and better profitability, track the trend in net margin and absolute earnings each reporting period and see whether they move in the same direction as the story you bought into.
What The 46% Fall In Newgen Software Technologies Now Asks You To Believe
Newgen Software Technologies now trades at ₹476, with the share price down 46.3% over the past year. The selected Narrative still places its Fair Value above the current price, arguing that the market underestimates the recurring, annuity style revenue base and AI focused product push.
The core question is whether that view holds. A buyer today would need to believe subscription heavy, AI infused workflows and international contracts can keep strengthening earnings quality even if large deals in India and EMEA stay slow and pricing on services remains under pressure.
"The continued shift towards SaaS and subscription contracts, with subscription revenues up 24% in FY 26 and SaaS revenues up 36%, has raised annuity revenue to 62% of FY 26 revenue and 71% of Q1 FY 27 revenue. This can improve cash flow visibility, support net margins and help investors reassess the quality of Newgen Software Technologies' earnings."
One Narrative has put a figure on that disagreement. → See the Narrative with its higher Fair Value, assumptions and all
Looking Beyond Newgen Software Technologies
Newgen Software Technologies is trying to turn workflows into predictable, software driven processes. You can see the appeal of that promise.
Step away and you find another piece of the same puzzle. Some enterprises want not just workflows, but a control room for sensitive data.
Here, a different vendor focuses on wiring data, permissions and audit trails into one operating layer. It aims to slot AI tools directly into those live environments.
That approach tries to address a similar problem from the infrastructure side. As regulated sectors refine secure AI requirements, this kind of platform could become pivotal.
The case is on the record, with the assumptions it rests on. → See the Narrative that values this company 82% above its price
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Companies discussed in this article include NEWGEN.nsei .
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
